Research Catalog

Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.

Title
Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.
Author
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health.
Publication
Washington : U. S. Govt. Print. Off., 1974.

Items in the Library & Off-site

Filter by

1 Item

StatusFormatAccessCall NumberItem Location
TextRequest in advance JLE 76-1353Offsite

Details

Additional Authors
United States. Drug Bioequivalence Study Panel. Drug bioequivalence.
Description
iv, 243 p. : ill.; 24 cm.
Subject
  • Drugs > Standards
  • Pharmaceutical industry > Quality control
Note
  • "Drug bioequivalence; a report of the Office of Technology Assessment Drug Bioequivalence Study Panel": p. 3-81.
Bibliography (note)
  • Bibliography: p. 64-72.
Call Number
JLE 76-1353
LCCN
75601173
OCLC
  • 1342332
  • NYPG764195686-B
Author
United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health.
Title
Brand names and generic drugs, 1974 : hearing before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, Ninety-third Congress, second session, on examination of the Office of Technology Assessment report of the Drug Bioequivalence Study Panel, July 22, 1974.
Imprint
Washington : U. S. Govt. Print. Off., 1974.
Bibliography
Bibliography: p. 64-72.
Added Author
United States. Drug Bioequivalence Study Panel. Drug bioequivalence.
Research Call Number
JLE 76-1353
View in Legacy Catalog